Data as of Mar 07
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for WuXi Pharmatech (Cayman) Inc have a median target of 40.00, with a high estimate of 43.00 and a low estimate of 34.40. The median estimate represents a +10.71% increase from the last price of 36.13.
The current consensus among 8 polled investment analysts is to Buy stock in WuXi Pharmatech (Cayman) Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.